Fig. 5From: Analysis of metabolites in human gut: illuminating the design of gut-targeted drugsDistributions Bemis-Murcko (BM) scaffols across the different compound sets; top-15 scaffolds for each set are shown. a DrugBank; b Gut/Serum; c Gut-noFL. Gut-FL was not included as it contains a negligible number of scaffolds, in spite of its large size. The bars with no scaffolds correspond to the molecules with no rings, and therefore no BM scaffoldsBack to article page